CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 48 enrolled
Drug / intervention
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg +1 moredrug
Likely dose
Omeprazole 20 mg + Sodium Bicarbonate 1100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01587885
NCT01587885Phase 4Completed
CompareCT.gov

Protocol PT 11-29: Randomized, Open-label, Cross-over Pilot Study to Evaluate and Compare Two Omeprazole Containing Products for Relief of Frequent Heartburn

Bayer·interventional·Posted Apr 30, 2012·Updated Mar 11, 2015

In Brief

A Phase 4 clinical trial evaluating Omeprazole 20 mg + Sodium Bicarbonate 1100 mg and Omeprazole 20 mg for Heartburn. Completed, enrolled 48 participants.

Detailed Summary

This study will evaluate a single ingredient product (omeprazole 20 mg) with a combination product capsule (omeprazole 20 mg + sodium bicarbonate 1100 mg) in participants with frequent heartburn.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeartburn
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 30, 2012
Enrollment StartJan 1, 2012
Primary CompletionApr 1, 2012
Study CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.2 years ago

Interventions

Omeprazole 20 mg + Sodium Bicarbonate 1100 mgdrug

Capsules, orally

Omeprazole 20 mgdrug

Tablets, orally